ABSTRACT:
Clozapine is widely used to treat schizophrenia, but it has low oral bioavailability (<27%), degradation in GI environment, and high hepatic first-pass metabolism. The present research work aimed to overcome these issues by designing tailored clozapine loaded nanoparticles (NPs) and to deliver them to the brain via the intranasal pathway, to enhance brain targeting of antipsychotic drugs. Chitosan–sodium tri polyphosphate and chitosan–sodium alginate NPs loaded with Clozapine (CZ) were prepared by using ionotropic gelation and ionotropic pre-gelation methods. SEM showed spherical-shaped NPs, while the average dynamic size was measured by dynamic light scattering. Optimized clozapine loaded nanoparticles (C2,C7) showed 56% and 55% encapsulation efficiency, respectively, with particle sizes of (453 - 425)nm. The in vitro drug release from formulas exhibited sustained release of clozapine, were 69.2% and 98.7% respectively, within 24h. The release profile was characterized by an initial fast release in phosphate buffer, followed by a continuous release phase; the drug release mechanism from polymers was in correspondence with Fickian diffusion. CZ-loaded NPs are a promising strategy for managing schizophrenia. Nose-to-brain pathway enhances safety and patient compliance of CZ.
Cite this article:
Mireille Aldeir, Mohammad Othman. Preparation and in vitro Evaluation of Clozapine Chitosan Nanoparticles for Intranasal Administration. Research Journal Pharmacy and Technology. 2026;19(3):1265-2. doi: 10.52711/0974-360X.2026.00181
Cite(Electronic):
Mireille Aldeir, Mohammad Othman. Preparation and in vitro Evaluation of Clozapine Chitosan Nanoparticles for Intranasal Administration. Research Journal Pharmacy and Technology. 2026;19(3):1265-2. doi: 10.52711/0974-360X.2026.00181 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-3-42
REFERENCES:
1. Chavda VP, Jogi G, Shah N, et al. Advanced particulate carrier-mediated technologies for nasal drug delivery. J Drug Deliv Sci Technol. 2022; 74:103569.
2. Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood–brain barrier: Structure, regulation and drug delivery. Signal Transduct Target Ther. 2023; 8(1): 1-27.
3. Kadian R. Nanoparticles: A Promising Drug Delivery Approach. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(1):30-35.
4. Britto JG, Ramachandra. Relapse Prevention among Caregivers of Patients with Schizophrenia. Asian Journal of Nursing Education and Research. 2014; 4(1): 140–4.
5. Orsolini L, Pompili S, Volpe U. Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects. Journal of Clinical Medicine. 2022; 11(17): 5040.
6. Nagasree K, Pallavi K, Sri S R. Preparation and Evaluation of Niosomal Transdermal Patch of Clozapine. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(1): 13–8.
7. Atodariya PP, Raj HA, Jain VC. Simultaneous Estimation of Lamotrigine and Clozapine by Simultaneous equation method in their Synthetic Mixture which use in Schizophrenia. Asian Journal of Pharmaceutical Analysis. 2015; 5(2): 79.
8. Velupula R, Janapareddi K, Krishnaveni J. Development and evaluation of clozapine intranasal mucoadhesive in situ gels for brain targeting. J Drug Deliv Ther. 2019; 9(s): 198-207.
9. Patel HP, Gandhi PA, Chaudhari PS, et al. Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies. J Drug Deliv Sci Technol. 2021; 64.
10. Lombardo R, Ruponen M, Rautio J, et al. Development of Lyophilised Eudragit® Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration. Pharmaceutics. 2023; 15(5).
11. Tan MS, Parekh HS, Pandey P, Siskind DJ, Falconer JR. Development and optimization of clozapine-loaded PLGA nanoparticles for nose-to-brain delivery using supercritical fluid. PSWC 2020 Virtual. 2020.
12. Patel HP, Chaudhari PS, Gandhi PA, et al. Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. Int J Pharm. 2021; 600: 120474.
13. Patel HP, Desai PH, Patel R V, et al. Colloids and Surfaces B: Biointerfaces Clozapine-laden carbon dots delivered to the brain via an intranasal pathway: Synthesis, characterization, ex vivo, and in vivo studies. Colloids Surfaces B Biointerfaces. 2024; 237:113862.
14. Łukasiewicz S, Mikołajczyk A, Szczęch M, Szczepanowicz K, Warszyński P, Dziedzicka-Wasylewska M. Encapsulation of clozapine into polycaprolactone nanoparticles as a promising strategy of the novel nanoformulation of the active compound. J Nanoparticle Res. 2019; 21(7): 149.
15. Lunkad SH, Sarode S. Formulation and Evaluation of Mucoadhesive Tablet of Valsartan. Asian Journal of Pharmaceutical Research. 2019; 9(4): 229.
16. Vasquez-Martínez N, Guillen D, Moreno-Mendieta SA, Sanchez S, Rodríguez-Sanoja R. The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants. Polym. 2023; 15(7): 1615.
17. Nazir A, Kumari N, Bharti Gupta N, Gupta R, Chandel A, C. Varghese A. Recent Advances on Chitosan Nanoparticles. Asian Journal of Pharmaceutical Research. 2023; 13(3): 158–62.
18. Shim S, Yoo HS. The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery. Mar Drugs. 2020; 18(12): 605.
19. Gokilavani S, Vijayabharathi V, Parthasarathy R. Physico-Chemical Characteristics and Antibacterial Activity of Chitosan Extracted from Shell of Crab Paratelphusa hydrodromous. Asian Journal of Research in Pharmaceutical Sciences. 2014;4(3):125–8.
20. Kumari GD, Raksha G, Deepak K, Anjana G, Mary CS. A review on chitosan nanoparticle as a drug delivery system. Asian Journal of Pharmaceutical Research. 2020; 10(4): 299-306. doi:10.5958/2231-5691.2020.00051.9
21. Khan AR, Liu M, Khan MW, Zhai G. Progress in brain targeting drug delivery system by nasal route. J Control Release. 2017; 268: 364-389.
22. Alghareeb S, Ekenna I, Asare-Addo K, Conway BR, Adebisi AO. Chitosan nanoparticles for nasal drug delivery. J Drug Deliv Sci Technol. 2025; 105: 106623.
23. Alehosseini E, Shahiri Tabarestani H, Kharazmi MS, Jafari SM. Physicochemical, Thermal, and Morphological Properties of Chitosan Nanoparticles Produced by Ionic Gelation. Foods. 2022; 11(23): 3841.
24. Gagliardi M, Chiarugi S, De Cesari C, et al. Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications. Int J Mol Sci. 2023; 24(7): 6590.
25. Nazir A, Kumari N, Bharti Gupta N, Gupta R, Chandel A, C. Varghese A. Recent Advances on Chitosan Nanoparticles. Asian Journal of Pharmaceutical Research. 2023; 13(3): 158-162.
26. Khandbahale SV, Saudagar RB. Nanoparticle-A Review. Asian Journal of Research in Pharmaceutical Sciences. 2017; 7(3): 162–2.
27. Rathore P, Mahor A, Jain S, Haque A, Kesharwani P. Formulation development, in vitro and in vivo evaluation of chitosan engineered nanoparticles for ocular delivery of insulin. RSC Adv. 2020; 10(71): 43629-43639.
28. Debnath S, Kumar RS, Niranjan Babu M. Ionotropic Gelation-A Novel Method to Prepare Chitosan Nanoparticles. Research J Pharm and Tech. 2011; 4(4): 492-495.
29. Rani NS, Krishna MT, V. Saikishore. Design and Development of Sweet Potato Starch Blended Sodium Alginate Mucoadhesive Microcapsules of Glipizide. Research Journal of Pharmaceutical Dosage Forms and Technology. 2011; 3(1): 12–6.
30. Niculescu AG, Grumezescu AM. Applications of Chitosan-Alginate-Based Nanoparticles—An Up-to-Date Review. Nanomaterials. 2022; 12(2): 186.
31. Yeerong K, Chantawannakul P, Anuchapreeda S, et al. Chitosan Alginate Nanoparticles of Protein Hydrolysate from Acheta domesticus with Enhanced Stability for Skin Delivery. Pharm. 2024; 16(6): 724.
32. Valencia MS, Silva Júnior MF da, Xavier-Júnior FH, et al. Characterization of curcumin-loaded lecithin-chitosan bioactive nanoparticles. Carbohydr Polym Technol Appl. 2021; 2:100119.
33. Ahmad N, Khan MR, Palanisamy S, Mohandoss S. Anticancer Drug-Loaded Chitosan Nanoparticles for In Vitro Release, Promoting Antibacterial and Anticancer Activities. Polymers (Basel). 2023; 15(19): 3925.
34. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 1997; 63(1): 125-132.
35. Chella S, Kasimedu S, Pommala N, Thulluru A, Gandla M, Vadamala PR. Chitosan Nanoparticles Enhance Permeability of Rizatriptan in Mucoadhesive Buccal Films: A Promising approach for Improved Drug Delivery. Res J Pharm Technol. 2025; 18(3): 1308-1316.
36. Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P. Development of a new drug carrier made from alginate. J Pharm Sci. 1993; 82(9): 912-917.
37. Yousfan A, Rubio N, Natouf AH, et al. Preparation and characterisation of PHT-loaded chitosan lecithin nanoparticles for intranasal drug delivery to the brain. RSC Adv. 2020; 10(48): 28992-29009.
38. Fawaz W, Hasian J, Alghoraibi I. Preparation, Characterization, and Release Profile Study of Vincristine Sulfate-loaded Polycaprolactone Nanoparticles. Micro Nanosyst. 2023; 15(4): 300-307.
39. Gupta S, Kesarla R, Chotai N, Misra A, Omri A. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability. Biomed Res Int. 2017; 2017: 5984014.
40. Abdulla NA, Balata GF, El-ghamry HA, Gomaa E. Intranasal delivery of Clozapine using nanoemulsion-based in-situ gels: An approach for bioavailability enhancement. Saudi Pharm J. 2021; 29(12): 1466-1485.
41. Darwish AB, Mohsen AM, Elshebiney S, Elgohary R, Younis MM. Development of chitosan lipid nanoparticles to alleviate the pharmacological activity of piperine in the management of cognitive deficit in diabetic rats. Sci Rep. 2024; 14(1): 8247.
42. Zhang Y, Huo M, Zhou J, et al. DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles. AAPS J. 2010; 12(3): 263.
43. Waqas MK, Safdar S, Buabeid M, Ashames A, Akhtar M, Murtaza G. Alginate-coated chitosan nanoparticles for pH-dependent release of tamoxifen citrate. J Exp Nanosci. 2022; 17(1): 522-534.
44. Kiaie N, Aghdam RM, Tafti SHA, Emami SH. Statistical optimization of chitosan nanoparticles as protein vehicles, using response surface methodology. J Appl Biomater Funct Mater. 2016;14(4): e413-e422.
45. Tan MSA, Pandey P, Falconer JR, Siskind DJ, Balmanno A, Parekh HS. Clozapine-Encapsulated Binary Mixed Micelles in Thermosensitive Sol-Gels for Intranasal Administration. Gels. 2022; 8(1).
46. Ali AMA, Ali AA, Maghrabi IA. Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluation. Acta Pharm. 2015; 65(2): 133-146.
47. Kota RB, Kaliyaperumal S. Superporous Hydrogels as Super Disintegrants in Formulating Oral Disintegrating Tablets of Clozapine for the Treatment of Schizophrenia. Int J Drug Deliv Technol. 2024; 14(3): 1716-1721.
48. Muchtaromah B, Minarno EB, Annisa R, et al. Synthesis and Optimization of Nanoparticle Chitosan-Tripolyphospate Centella asiatica using Ionic Gelation Method with Difference Sonification Time. Res J Pharm Technol. 2023; 16(8): 3847-3851.
49. Prasad SR, K. Elango, S. Daisy Chellakumari, S. Dharani. Preparation, Characterization and Anti-Inflammatory Activity of Chitosan Stabilized Silver Nanoparticles. Research Journal of Pharmaceutical Dosage Forms and Technology. 2013; 5(3): 161–7.
50. Sorasitthiyanukarn FN, Muangnoi C, Ratnatilaka Na Bhuket P, Rojsitthisak P, Rojsitthisak P. Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment. Mater Sci Eng C. 2018; 93: 178-190.
51. Valentino A, Conte R, De Luca I, et al. Thermo-Responsive Gel Containing Hydroxytyrosol-Chitosan Nanoparticles (Hyt@tgel) Counteracts the Increase of Osteoarthritis Biomarkers in Human Chondrocytes. Antioxidants. 2022; 11(6): 1210.
52. Kumar Sukumaran S. Development and Evaluation of Naringenin Loaded Chitosan Nanoparticles for Improved Treatment of Neurotoxicity. Research J Pharm and Tech. 2020; 13(1): 129-134.
53. Rathore P, Mahor A, Jain S, Haque A, Kesharwani P. Formulation development, In vitro and in vivo evaluation of chitosan engineered nanoparticles for ocular delivery of insulin. RSC Adv. 2020; 10(71): 43629-43639.
54. Kunjachan S, Jose S, Lammers T. Understanding the mechanism of ionic gelation for synthesis of chitosan nanoparticles using qualitative techniques. Asian Journal of Pharmaceutics (AJP). 2010; 4(2): 148-153.
55. Abosabaa SA, Elmeshad AN, Arafa MG. Chitosan Nanocarrier Entrapping Hydrophilic Drugs as Advanced Polymeric System for Dual Pharmaceutical and Cosmeceutical Application: A Comprehensive Analysis Using Box-Behnken Design. Polymers. 2021; 13(5): 677.
56. Kundu M, Chatterjee TK, Mandal D, Dutta S, Roy T. Preparation and Evaluation of Metformin Microspheres by Ionotropic Gelation Method. Res J Pharm Technol. 2024; 17(10): 5079-5084.
57. Asfour MH, Salama AAA, Mohsen AM. Fabrication of All-Trans Retinoic Acid loaded Chitosan/Tripolyphosphate Lipid Hybrid Nanoparticles as a Novel Oral Delivery Approach for Management of Diabetic Nephropathy in Rats. J Pharm Sci. 2021; 110(9): 3208-3220.
58. Jiang T, Wang Y, Yu Z, Du L. Synthesis, characterization of chitosan/tripolyphosphate nanoparticles loaded with 4-chloro-2-methylphenoxyacetate sodium salt and its herbicidal activity against Bidens pilosa L. Sci Reports. 2024; 14(1): 1-12.
59. Ma Y, Liu P, Ye K, et al. Preparation, Characterization, In Vitro Release, and Antibacterial Activity of Oregano Essential Oil Chitosan Nanoparticles. Foods. 2022; 11(23): 3756.
60. Bruschi ML. Mathematical models of drug release. Strategies to Modify the Drug Release from Pharmaceutical Systems. 2015: 63-86.